Ms Leezil Peneder
Department Administrator

Tel: +27-31-240 2557
Fax: +27-31-240 2576

Dr Verena Gounden


Dr Verena Gounden


 +27 (0)31 240 2557




Research Interests

Mass spectrometry clinical applications, pharmacogenetics. Biomarkers of renal disease


Pathologist  ( Acting HOD)


Dr Verena Gounden undertook her specialist registrar training at NHLS labs at the Charlotte Maxeke Johannesburg Academic and Chris Hani Baragwanath Hospitals. Dr Gounden joined the Department of Chemical Pathology at IALCH as a consultant in January 2011. As of 01.09.2012 Dr Gounden went for a 2 year NIH Research Fellowship in Washington, USA.
 List of publications  1.  An improved micro-method for the measurement of steroid profiles by APPI-LC-MS/MS and its use in assessing diurnal effects on steroid concentrations and optimizing the diagnosis and treatment of adrenal insufficiency and CAH.
Stolze BR, Gounden V, Gu J, Elliott EA, Masika LS, Abel BS, Merke DP, Skarulis MC, Soldin SJ.

J Steroid Biochem Mol Biol. 2015 Dec 22. pii: S0960-0760(15)30165-5. doi: 10.1016/j.jsbmb.2015.12.024. [Epub ahead of print] Review.

2. CUSUM-Logistic Regression analysis for the rapid detection of errors in clinical laboratory test results.

Sampson ML, Gounden V, van Deventer HE, Remaley AT.Clin Biochem. 2015 Oct 30. pii: S0009-9120(15)00506-8. doi: 10.1016/j.clinbiochem.2015.10.019. [Epub ahead of print]

Gounden V, Zhao Z.
Ann Clin Biochem. 2015 Oct 21. pii: 0004563215609372. [Epub ahead of print]
Reddy A, Gounden V.
Clin Chem. 2015 Oct;61(10):1307-8. doi: 10.1373/clinchem.2015.240093. No abstract available.
5.Select item 263409695.
Debono M, Mallappa A, Gounden V, Nella AA, Harrison RF, Crutchfield CA, Backlund PS, Soldin SJ, Ross RJ, Merke DP.

Eur J Endocrinol. 2015 Dec;173(6):727-37. doi: 10.1530/EJE-15-0064. Epub 2015 Sep 4.

6.Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.

Korde N, Roschewski M, Zingone A, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Wu P, Morrison C, Costello R, Zhang Y, Burton D, Mulquin M, Zuchlinski D, Lamping L, Carpenter A, Wall Y, Carter G, Cunningham SC, Gounden V, Sissung TM, Peer C, Maric I, Calvo KR, Braylan R, Yuan C, Stetler-Stevenson M, Arthur DC, Kong KA, Weng L, Faham M, Lindenberg L, Kurdziel K, Choyke P, Steinberg SM, Figg W, Landgren O.
JAMA Oncol. 2015 Sep;1(6):746-54. doi: 10.1001/jamaoncol.2015.2010.
Seape T, Gounden V, van Deventer HE, Candy GP, George JA.
Ann Clin Biochem. 2016 Jan;53(Pt 1):58-66. doi: 10.1177/0004563215579695. Epub 2015 Mar 12.


8. Use of micro-HPLC-MS/MS method to assess diurnal effects on steroid hormones.

Stolze BR, Gounden V, Gu J, Abel BS, Merke DP, Skarulis MC, Soldin SJ.

Clin Chem. 2015 Mar;61(3):556-8. doi: 10.1373/clinchem.2014.232546. Epub 2014 Dec 17. No abstract available.

9. Interference of cerebrospinal fluid total protein measurement by povidone-iodine contamination.

Gounden V, Sacks DB, Zhao Z.

Clin Chim Acta. 2015 Feb 2;440:3-5. doi: 10.1016/j.cca.2014.10.008. Epub 2014 Oct 16.

10. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.

Kuzmina Z, Gounden V, Curtis L, Avila D, Rnp TT, Baruffaldi J, Cowen EW, Naik HB, Hasni SA, Mays JW, Mitchell S, Baird K, Steinberg SM, Pavletic SZ.

Am J Hematol. 2015 Feb;90(2):114-9. doi: 10.1002/ajh.23885. Epub 2014 Nov 24.

11. LC-MS/MS detection of increased androstenedione levels in patients receiving danazol therapy.

Gounden V, El-Maouche D, Stolze BR, Muniyappa R, Soldin SJ.

Ther Drug Monit. 2014 Dec;36(6):828-9. doi: 10.1097/FTD.0000000000000086. No abstract available.

12. Tacrolimus measurement: building a better immunoassay.

Gounden V, Soldin SJ.

Clin Chem. 2014 Apr;60(4):575-6. doi: 10.1373/clinchem.2013.220012. Epub 2014 Jan 10. No abstract available.

13. A pilot study: subclinical hypothyroidism and free thyroid hormone measurement by immunoassay and mass spectrometry.

Gounden V, Jonklaas J, Soldin SJ.
Clin Chim Acta. 2014 Mar 20;430:121-4. doi: 10.1016/j.cca.2013.12.034. Epub 2013 Dec 31.

14. Clinical use of reference intervals derived from some CALIPER studies questioned.

Gounden V, Soldin SJ.

Clin Chem. 2014 Feb;60(2):416-7. doi: 10.1373/clinchem.2013.214684. Epub 2013 Dec 20. No abstract available.

15. Blood collection tube-related alterations in analyte concentrations in quality control material and serum specimens.

Bowen RA, Sattayapiwat A, Gounden V, Remaley AT.

Clin Biochem. 2014 Feb;47(3):150-7. doi: 10.1016/j.clinbiochem.2013.11.003. Epub 2013 Nov 14.

16. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.

Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O.
Leuk Lymphoma. 2014 Jun;55(6):1402-3. doi: 10.3109/10428194.2013.831091. Epub 2013 Dec 2. No abstract available.

17. A not so crystal-clear case.

Gounden V, Rampursat Y.

Clin Chem. 2012 Aug;58(8):1264-5. doi: 10.1373/clinchem.2011.179713. No abstract available.

18. Multi point of care instrument evaluation for use in anti-retroviral clinics in South Africa.

Gounden V, George J.

Clin Lab. 2012;58(1-2):27-40.

19. Presence of the CYP2B6 516G> T polymorphism, increased plasma Efavirenz concentrations and early neuropsychiatric side effects in South African HIV-infected patients.

Gounden V, van Niekerk C, Snyman T, George JA.
AIDS Res Ther. 2010 Aug 19;7:32. doi: 10.1186/1742-6405-7-32.

Contact Webmaster | View the Promotion of Access to Information Act | View our Privacy Policy
© University of KwaZulu-Natal: All Rights Reserved